 LOS ALTOS, Calif., Aug. 16, 2021 PRNewswire -- Unicycive Therapeutics, Inc. Nasdaq: UNCY, a clinical stage biotechnology company developing therapies for patients with kidney disease, today reported financial results for the second quarter ended June 30, 2021. 